JWH-073

Chemical compound

JWH-073

Legal status
Legal status|

* BR: Class F2 (Prohibited psychotropics)[1]
* CA: Schedule II
* DE: Anlage II (Authorized trade only, not prescriptible)
* UK: Class B
* US: Schedule I
* Illegal in Latvia[2] & Poland

Identifiers

IUPAC name

* Naphthalen-1-yl-(1-butylindol-3-yl)methanone

CAS Number|

* 208987-48-8 Y

PubChem CID|

* 10471670

ChemSpider|

* 8647081 N

UNII|

* BBX3BP2772

CompTox Dashboard (EPA)|

* DTXSID20175042

ECHA InfoCard| 100.230.192
Chemical and physical data
Formula| C23H21NO
Molar mass| 327.427 g·mol−1
3D model (JSmol)|

* Interactive image

SMILES

* CCCCN1C=C(C2=CC=CC=C21)C(=O)C3=CC=CC4=CC=CC=C43

InChI

* InChI=1S/C23H21NO/c1-2-3-15-24-16-21(19-12-6-7-14-22(19)24)23(25)20-13-8-10-17-9-4-5-11-18(17)20/h4-14,16H,2-3,15H2,1H3 N

* Key:VCHHHSMPMLNVGS-UHFFFAOYSA-N N

NY (what is this?) (verify)

JWH-073, a synthetic cannabinoid, is an analgesic chemical from the naphthoylindole family that acts as a full agonist[3] at both the CB1 and CB2 cannabinoid receptors. It is somewhat selective for the CB1 subtype, with affinity at this subtype approximately 5× the affinity at CB2.[4] The abbreviation JWH stands for John W. Huffman, one of the inventors of the compound.

On 20 April 2009, JWH-073 was claimed by researchers at the University of Freiburg to have been found in a "fertiliser" product called "Forest Humus", along with another synthetic cannabinoid (C8)-CP 47,497.[5] These claims were confirmed in July 2009 when tests of Spice product, seized after the legal ban on JWH-018 had gone into effect in Germany, were shown to contain the unregulated compound JWH-073 instead.[6]

Analgesic effects of cannabinoid ligands have been demonstrated in multiple animal pain models (neuropathic, nociceptive).[7]

These compounds work by mimicking the body's naturally-produced endocannabinoid hormones such as 2-arachidonoylglycerol and anandamide, which are biologically active and can exacerbate or inhibit nerve signaling.[7]

As the cause is poorly understood in chronic pain states, more research and development must be done before we can realize the therapeutic potential of this class of biologic compounds.[7]

## Pharmacology[edit]

JWH-073 has been shown to produce behavioral effects very similar to THC in animals.[8]

Its effects are produced by binding and acting as an agonist to the CB1 and CB2 cannabinoid receptors. The CB1 receptor is found in the brain. JWH-073 binds to CB1 with a higher affinity than THC. CB2 is found outside the brain, mostly in the immune system. The binding with CB2 receptors has been shown to be similar between JWH-073 and THC.[8]

A search in the literature yielded no published studies of the effects of JWH-073 in humans, but these studies in animals suggest with high probability that JWH-073 produces effects very similar to those of THC in humans.[8]

## Derivatives[edit]

The 4'-methyl derivative of JWH-073 has been encountered as an ingredient of synthetic cannabis blends in Germany and several other European countries since 2010.[9] The 4'-methoxy derivative JWH-080 is also known to be a potent cannabinoid agonist and has been banned in some countries, though it is unclear if it has also been used in synthetic cannabis smoking blends.

4'-Methyl-JWH-073

## Legal status[edit]

### United States[edit]

See also: JWH-018

1 g of JWH-073

The US DEA temporarily declared JWH-073 a schedule I controlled substance on 1 March 2011 through 76 FR 11075, and permanently instated the same schedule on 9 July 2012 in the Section 1152 of the Food and Drug Administration Safety and Innovation Act.[10]

### Australia[edit]

See also: JWH-018

On 8 July 2011 the AUS government banned the sale of JWH-073.[11] JWH-073 is considered a Schedule 9 prohibited substance in Australia under the Poisons Standard (October 2015).[12] A Schedule 9 substance is a substance which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities.[12]

### New Zealand[edit]

On 8 May 2014 the New Zealand government banned the sale of JWH-073.[13]

### Turkey[edit]

On 7 January 2011 the Turkey government banned the sale of JWH-073.[14]

## See also[edit]

* HU-210
* JWH-019
* JWH-081
* MEPIRAPIM

## References[edit]

1. ^ Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
2. ^ "Grozījumi Ministru kabineta 2005.gada 8.novembra noteikumos Nr.847 "Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem"". Legal Acts of the Republic of Latvia (in Latvian).
3. ^ Lisa K. Brents, Anna Gallus-Zawada, Anna Radominska-Pandya, Tamara Vasiljevik, Thomas E Prisinzano, William E Fantegrossi, Jeffery H Moran, Paul L Prather (2012). "Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity". Biochemical Pharmacology. 83 (7): 952–961. doi:10.1016/j.bcp.2012.01.004. hdl:1808/22684. PMID 22266354. "JWH-073 displays equivalent efficacy to that of the CB1R full agonist CP-55,940"`{{cite journal}}`: CS1 maint: multiple names: authors list (link)
4. ^ Aung MM, Griffin G, Huffman JW, Wu M, Keel C, Yang B, et al. (August 2000). "Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding". Drug and Alcohol Dependence. 60 (2): 133–40. doi:10.1016/S0376-8716(99)00152-0. PMID 10940540.
5. ^ Markuse P. "Forest Humus – Enthält synthetische Cannabinoide". Pierre Markuse Blog (in German). Archived from the original on 23 July 2012.
6. ^ Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, Beuerle T (October 2009). "Spice: a never ending story?". Forensic Science International. 191 (1–3): 58–63. doi:10.1016/j.forsciint.2009.06.008. PMID 19589652.
7. ^ a b c Rani Sagar D, Burston JJ, Woodhams SG, Chapman V (December 2012). "Dynamic changes to the endocannabinoid system in models of chronic pain". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 367 (1607): 3300–11. doi:10.1098/rstb.2011.0390. PMC 3481532. PMID 23108548.
8. ^ a b c "DEA Diversion Control Division". Archived from the original on August 3, 2010. Retrieved August 5, 2010.
9. ^ "EMCDDA Annual Report 2010" (PDF). Archived from the original (PDF) on 2012-03-14. Retrieved 2011-10-02.
10. ^ "Schedules of Controlled Substances: Temporary Placement of Four Synthetic Cannabinoids Into Schedule I". DEA Office of Diversion Control. Retrieved 11 March 2014.
11. ^ "Final Decisions & Reasons for Decisions by Delegates of the Secretary to the Department of Health and Ageing" (PDF). Department of Health and Ageing. Australian Government. Archived from the original (PDF) on June 4, 2012. Retrieved August 2, 2011.
12. ^ a b "Poisons Standard". Federal Register of Legislation. Government of Australia. October 2015.
13. ^ "Synthetic cannabis › What they are". NZ Drug Foundation. Archived from the original on 2015-09-21. Retrieved 2014-05-11.
14. ^ › Turkish Drug Law

* v
* t
* e

Cannabinoids

Phytocannabinoids
(comparison)|

| Cannabibutols|

* CBB

|

Cannabichromenes|

* CBC
* CBCA
* CBCA-A
* CBCB
* CBCBA
* CBCP
* CBCPA
* CBCV
* CBCVA
* CBCQ

Cannabicyclols|

* CBL
* CBLA
* CBLB
* CBLP
* CBLPA
* CBLV
* CBLVA

Cannabidiols|

* CBD
* CBDA
* CBD-C1
* CBD-C5
* CBDB
* CBDBA
* CBDD
* CBDH
* CBDP
* CBDPA
* CBDM
* CBDMA
* CBDV
* CBDVA
* CBDQ

Cannabielsoins|

* CBE
* CBEA
* CBEA-A
* CBEA-B
* CBEB
* CBEP
* CBEPA
* CBEV

Cannabigerols|

* CBG
* CBGA
* CBGB
* CBGBA
* CBGM
* CBGAM
* CBGP
* CBGPA
* CBNR
* CBNRA
* CBNRA-A
* CBGV
* CBGVA
* CBGVA-A
* CBGQ

Cannabiphorols|

* CBP

Cannabinols|

* CBN
* CBNA
* CBN-C1
* CBN-C2
* CBN-C4
* CBNM
* CBND
* CBNDA
* CBNP
* CBNPA
* CBVD
* CBVDA

Cannabitriols|

* CBT
* CBTA
* CBTB
* CBTV
* CBTVA
* CBTP
* CBTPA

Cannabivarins|

* CBV
* CBVA

Delta-8-tetrahydrocannabinols|

* Delta-8-THC
* Delta-8-THCA
* Delta-8-THCA-A
* Delta-8-THCB
* Delta-8-THCP
* Delta-8-THCV

Delta-9-tetrahydrocannabinols|

* Delta-9-THC (THC)
* THCA
* THCMA
* THCA-A
* THCA-B
* THCBA
* THCA-C4
* THCC
* THCA-C1
* THCA-A-C1
* THCA-B-C1
* THCB
* THCH
* THCP
* THCPA
* THCV
* THCVA
* THCQ

Delta-10-Tetrahydrocannabinols|

* Delta-10-THC

Miscellaneous cannabinoids|

* Δ8-iso-THC
* Δ4(8)-iso-THC
* 7,8-Dihydrocannabinol
* 8,9-Dihydrocannabidiol
* CBCF
* Cannabicitran
* CBF
* Cannabiglendol
* CBM
* CBR
* CBRPA
* Caryophyllene
* DCBF
* Alkylamides
* Epigallocatechin gallate
* Gallocatechol
* Hexahydrocannabinol (HHC)
* Perrottetinene
* Serinolamide A
* Yangonin

Active metabolites|

* 3'-OH-THC
* 7-OH-CBD
* 8,11-DiOH-THC
* 11-COOH-THC
* 11-OH-CBN
* 11-OH-HHC
* 11-OH-Δ8-THC
* 11-OH-Δ9-THC

Endocannabinoids|

* Arachidonoyl ethanolamide (AEA; anandamide)
* 2-Arachidonoylglycerol (2-AG)
* 2-Arachidonyl glyceryl ether (2-AGE; noladin ether)
* 2-Oleoylglycerol (2-OG)
* N-Arachidonoyl dopamine (NADA)
* N-Arachidonylglycine (NAGly)
* 2-Arachidonoyl lysophosphatidylinositol (2-ALPI)
* N-Arachidonoyl serotonin (AA-5-HT)
* Docosatetraenoylethanolamide (DEA)
* Lysophosphatidylinositol (LPI)
* Oleamide
* Oleoylethanolamide (OEA)
* Palmitoylethanolamide (PEA)
* RVD-Hpα
* Stearoylethanolamide (SEA)
* O-Arachidonoyl ethanolamine (O-AEA; virodhamine)

Synthetic
cannabinoid
receptor
agonists /
neocannabinoids|

| Classical cannabinoids
(dibenzopyrans)|

* 9-OH-HHC
* 9-Nor-9β-HHC
* A-40174
* A-41988
* A-42574
* Ajulemic acid
* AM-087
* AM-411
* AM-855
* AM-905
* AM-906
* AM-919
* AM-926
* AM-938
* AM-2389
* AM-4030
* AM-7438
* AM-11245
* AMG-1
* AMG-3
* AMG-36
* AMG-41
* CP 42,096
* Delta-3-THC
* Delta-4-THC
* Delta-7-THC
* Delta-10-THC
* Dexanabinol (HU-211)
* DMHP
* Dronabinol
* HU-210
* HU-243
* JWH-051
* JWH-056
* JWH-057
* JWH-065
* JWH-091
* JWH-102
* JWH-103
* JWH-124
* JWH-130
* JWH-133
* JWH-138
* JWH-139
* JWH-142
* JWH-143
* JWH-161
* JWH-186
* JWH-187
* JWH-188
* JWH-189
* JWH-190
* JWH-191
* JWH-215
* JWH-216
* JWH-217
* JWH-224
* JWH-225
* JWH-226
* JWH-227
* JWH-229
* JWH-230
* JWH-233
* JWH-247
* JWH-254
* JWH-256
* JWH-277
* JWH-278
* JWH-298
* JWH-299
* JWH-300
* JWH-301
* JWH-310
* JWH-336
* JWH-338
* JWH-339
* JWH-340
* JWH-341
* JWH-349
* JWH-350
* JWH-352
* JWH-353
* JWH-354
* JWH-355
* JWH-356
* JWH-357
* JWH-358
* JWH-359
* JWH-360
* JWH-361
* JWH-362
* KM-233
* L-759,633
* L-759,656
* Levonantradol (CP 50,5561)
* Menabitan
* Nabazenil
* Nabidrox (Canbisol)
* Nabilone
* Nabitan
* Naboctate
* O-224
* O-581
* O-774
* O-806
* O-823
* O-1057
* O-1125
* O-1191
* O-1238
* O-2048
* O-2113
* O-2365
* O-2372
* O-2373
* O-2383
* O-2426
* O-2484
* O-2545
* O-2694
* O-2715
* O-2716
* O-3223
* O-3226
* Parahexyl
* Pirnabine
* SP-111
* THC hemisuccinate
* THC-O-acetate
* THC-O-phosphate

|

Non-classical
cannabinoids|

* Cannabicyclohexanol
* Cannabinor
* CBD-DMH
* CP 47,497
* (C6)-CP 47,497
* (C9)-CP 47,497
* CP 55,244
* CP 55,940
* Delta-6-Cannabidiol
* Etrinabdione
* HU-308
* HU-320
* HU-331
* HU-336
* HU-345
* HU-446
* HU-465
* HU-910
* HUF-101
* Nonabine
* O-1376
* O-1422
* O-1601
* O-1656
* O-1657
* O-1660
* O-1663
* O-1871
* SPA-229
* Tinabinol

Adamantoylindoles|

* 5F-AKB-48
* APICA
* STS-135

Benzimidazoles|

* AZ-11713908
* AZD-1940
* BIM-018
* FUBIMINA
* MCHB-1
* PF-03550096
* RQ-00202730

Benzoylindoles|

* 1-Butyl-3-(2-methoxybenzoyl)indole
* 1-Butyl-3-(4-methoxybenzoyl)indole
* 1-Pentyl-3-(2-methoxybenzoyl)indole
* AM-630
* AM-679
* AM-694
* AM-1241
* AM-2233
* GW-405,833 (L-768,242)
* Pravadoline
* RCS-4
* WIN 54,461

Cyclohexylphenols|

* CP-47,947
* CP-55,940

Eicosanoids|

* AM-883
* AM-1346
* ACEA
* ACPA
* Methanandamide (AM-356)
* O-585
* O-689
* O-1812
* O-1860
* O-1861

Hydrocarbons|

* JWH-171
* JWH-176
* JWH-220

Indazole carboxamides|

* AB-PINACA
* AB-FUBINACA

Indazole-3-
carboxamides|

* 4F-MDMB-BINACA
* 4'Cl-CUMYL-PINACA
* 4'F-CUMYL-5F-PINACA
* 5Cl-APINACA
* 5F-ADB
* 5F-ADB-PINACA
* 5F-AMB
* 5F-APINACA
* 5F-CUMYL-PINACA
* 5F-EDMB-PINACA
* 5F-EMB-PINACA
* AB-CHMINACA
* AB-FUBINACA
* AB-FUBINACA 2-fluorobenzyl isomer
* AB-PINACA
* ADB-BINACA
* ADB-CHMINACA
* ADB-HEXINACA
* ADB-FUBINACA
* ADB-PINACA
* ADB-4en-PINACA
* ADB-5'Br-PINACA
* Adamantyl-THPINACA
* ADSB-FUB-187
* AMB-CHMINACA
* AMB-FUBINACA
* APINACA (AKB48)
* APP-FUBINACA
* CUMYL-4CN-BINACA
* CUMYL-CBMINACA
* CUMYL-FUBINACA
* CUMYL-NBMINACA
* CUMYL-PINACA
* CUMYL-THPINACA
* CUMYL-TSINACA
* EMB-FUBINACA
* FUB-APINACA
* MDMB-4en-PINACA
* MDMB-5Br-INACA
* MDMB-FUBINACA
* MDMB-CHMINACA
* MN-18
* PX-2
* PX-3

Indole-3-carboxamides|

* 4'F-CUMYL-5F-PICA
* 5F-ADBICA
* 5F-EDMB-PICA
* 5F-MDMB-PICA
* 5F-NNE1
* 5F-PCN
* 5F-SDB-006
* AB-FUBICA
* AB-PICA
* ADBICA
* ADB-FUBICA
* APICA
* BMS-F
* CUMYL-BICA
* CUMYL-CBMICA
* CUMYL-CHMICA
* CUMYL-NBMICA
* CUMYL-PICA
* CUMYL-5F-PICA
* FDU-NNE1
* MDMB-CHMICA
* MMB-CHMICA
* MMB-2201
* MN-25 (UR-12)
* NNE1
* PX-1
* Org 28312
* Org 28611
* SDB-006
* STS-135

Indole-3-carboxylates|

* 5F-PB-22
* FDU-PB-22
* FUB-PB-22
* QUCHIC (BB-22)
* QUPIC (PB-22)
* NM-2201

Naphthoylindazoles|

* THJ-018
* THJ-2201

Naphthoylindoles|

* 5F-JWH-398
* AM-1220
* AM-1221
* AM-1235
* AM-2201
* AM-2232
* CHM-081
* EAM-2201
* FUB-JWH-018
* JWH-004
* JWH-007
* JWH-009
* JWH-011
* JWH-015
* JWH-016
* JWH-018
* JWH-019
* JWH-020
* JWH-042
* JWH-043
* JWH-046
* JWH-047
* JWH-048
* JWH-049
* JWH-050
* JWH-070
* JWH-072
* JWH-073
* JWH-076
* JWH-077
* JWH-079
* JWH-080
* JWH-081
* JWH-082
* JWH-083
* JWH-093
* JWH-094
* JWH-095
* JWH-096
* JWH-097
* JWH-098
* JWH-099
* JWH-100
* JWH-116
* JWH-120
* JWH-122
* JWH-148
* JWH-149
* JWH-151
* JWH-153
* JWH-159
* JWH-160
* JWH-163
* JWH-164
* JWH-165
* JWH-166
* JWH-180
* JWH-181
* JWH-182
* JWH-189
* JWH-193
* JWH-198
* JWH-200
* JWH-210
* JWH-211
* JWH-212
* JWH-213
* JWH-234
* JWH-235
* JWH-236
* JWH-239
* JWH-240
* JWH-241
* JWH-242
* JWH-258
* JWH-259
* JWH-260
* JWH-261
* JWH-262
* JWH-265
* JWH-266
* JWH-267
* JWH-268
* JWH-387
* JWH-398
* JWH-416
* JWH-417
* JWH-422
* JWH-423
* JWH-424
* JWH-425
* MAM-1220
* MAM-2201
* NE-CHMIMO

Naphthoylpyrroles|

* JWH-030
* JWH-031
* JWH-032
* JWH-033
* JWH-036
* JWH-044
* JWH-045
* JWH-145
* JWH-146
* JWH-147
* JWH-150
* JWH-156
* JWH-243
* JWH-244
* JWH-245
* JWH-246
* JWH-292
* JWH-293
* JWH-307
* JWH-308
* JWH-309
* JWH-346
* JWH-347
* JWH-348
* JWH-363
* JWH-364
* JWH-365
* JWH-366
* JWH-367
* JWH-368
* JWH-369
* JWH-370
* JWH-371
* JWH-372
* JWH-373

Naphthylmethylindenes|

* JWH-171
* JWH-176
* JWH-220

Naphthylmethylindoles|

* JWH-175
* JWH-184
* JWH-185
* JWH-192
* JWH-194
* JWH-195
* JWH-196
* JWH-197
* JWH-199

Phenylacetylindoles|

* Cannabipiperidiethanone
* JWH-167
* JWH-201
* JWH-202
* JWH-203
* JWH-204
* JWH-205
* JWH-206
* JWH-207
* JWH-208
* JWH-209
* JWH-237
* JWH-248
* JWH-249
* JWH-250
* JWH-251
* JWH-252
* JWH-253
* JWH-302
* JWH-303
* JWH-304
* JWH-305
* JWH-306
* JWH-311
* JWH-312
* JWH-313
* JWH-314
* JWH-315
* JWH-316
* RCS-8

Pyrazolecarboxamides|

* 5F-AB-FUPPYCA
* 5F-AMPPPCA
* AB-CHFUPYCA

Pyrrolobenzoxazines|

* WIN 55,212-2

Quinolinyl esters|

* PB-22
* 5F-PB-22

Tetramethylcyclo-
propanoylindazoles|

* FAB-144

Tetramethylcyclo-
propanoylindoles|

* 5Br-UR-144
* 5Cl-UR-144
* A-796,260
* A-834,735
* FUB-144
* UR-144
* XLR-11
* XLR-12

Tetramethylcyclo-
propylindoles|

* UR-144
* XLR-11

Others|

* 2F-QMPSB
* 4-HTMPIPO
* 4CN-CUMYL-BUT7AICA
* 5F-PY-PICA
* 5F-PY-PINACA
* 5F-3-pyridinoylindole
* 5F-ADB-P7AICA
* 5F-CUMYL-P7AICA
* 5F-CUMYL-PEGACLONE
* A-836,339
* A-955,840
* Abnormal cannabidiol
* AB-001
* ADB-FUBIATA
* ADB-P7AICA
* AM-1248
* AM-1714
* BAY 38-7271
* BAY 59-3074
* BzODZ-EPyr
* CB-13
* CB-86
* CBS-0550
* CUMYL-4CN-B7AICA
* CUMYL-CB-MEGACLONE
* CUMYL-CH-MEGACLONE
* CUMYL-PEGACLONE
* EG-018
* GSK-554,418A
* GW-842,166X
* JTE 7-31
* LASSBio-881
* LBP-1
* Leelamine
* MDA-7
* MDA-19
* MEPIRAPIM
* NESS-040C5
* NMP-7
* O-889
* O-1269
* O-1270
* O-1399
* O-1602
* O-2220
* Olorinab
* PF-03550096
* PSB-SB-1202
* PTI-1
* PTI-2
* PTI-3
* QMPSB
* S-444,823
* S-777,469
* SER-601
* Tedalinab
* URB-447
* VSN-16
* WIN 56,098

Allosteric CBRTooltip Cannabinoid receptor ligands|

* AEF0117
* GAT100
* Org 27569
* Org 27759
* Org 29647
* PSNCBAM-1
* Pregnenolone
* RTI-371
* ZCZ-011

Endocannabinoid
enhancers
(inactivation inhibitors)|

* 4-Nonylphenylboronic acid
* AM-404
* Arachidonoyl serotonin
* Arvanil
* BIA 10-2474
* Biochanin A
* CAY-10401
* CAY-10429
* Genistein
* Guineesine
* IDFP
* JNJ 1661010
* JNJ-42165279
* JZL184
* JZL195
* Kaempferol
* LY-2183240
* MK-4409
* O-1624
* O-2093
* Oleoylethanolamide (OEA)
* Olvanil
* Palmitoylethanolamide (PEA)
* PF-04457845
* PF-622
* PF-750
* PF-3845
* PHOP
* URB-447
* URB-597
* URB-602
* URB-754
* VDM-11

Anticannabinoids
(antagonists/inverse
agonists/antibodies)|

* AM-251
* AM-281
* AM-630
* AM-1387
* AM-4113
* AM-6527
* AM-6545
* BML-190
* Brizantin (Бризантин)
* CAY-10508
* CB-25
* CB-52
* CB-86
* Dietressa (Диетресса)
* Drinabant (AVE1625)
* Hemopressin
* Ibipinabant (SLV319)
* JTE-907
* LH-21
* LY-320,135
* MDA-77
* MJ-15
* MK-9470
* NESS-0327
* NIDA-41020
* O-606
* O-1184
* O-1248
* O-1918
* O-2050
* O-2654
* Otenabant (CP-945,598)
* PF-514273
* PipISB
* PSB-SB-487
* Rimonabant (SR141716)
* Rosonabant (E-6776)
* SR-144,528
* Surinabant (SR147778)
* Taranabant (MK-0364)
* TM-38837
* VCHSR

* See also: Cannabinoid receptor modulators (cannabinoids by pharmacology)
* List of: AM cannabinoids
* JWH cannabinoids
* Designer drugs § Synthetic cannabimimetics

* v
* t
* e

Hallucinogens

Psychedelics
(5-HT2A
agonists)|

| Benzofurans|

* 2C-B-FLY
* 2CBFly-NBOMe
* 5-MeO-BFE
* 5-MeO-DiBF
* Bromo-DragonFLY
* F-2
* F-22
* TFMFly

|

Lyserg‐
amides|

* 1B-LSD
* 1cP-LSD
* 1P-ETH-LAD
* 1P-LSD
* 1cP-AL-LAD
* 1cP-MiPLA
* 1V-LSD
* 2-Butyllysergamide
* 3-Pentyllysergamide
* AL-LAD
* ALD-52
* BU-LAD
* Diallyllysergamide
* Dimethyllysergamide
* ECPLA
* Ergometrine
* ETH-LAD
* IP-LAD
* LAE-32
* LAMPA
* LPD-824
* LSA
* LSD
* LSD-Pip
* LSH
* LSM-775
* LSZ
* Methylergometrine
* MIPLA
* Methysergide
* MLD-41
* PARGY-LAD
* PRO-LAD

Phenethyl‐
amines|

| 2C-x|

* 2C-B
* 2C-B-AN
* 2C-Bn
* 2C-Bu
* 2C-C
* 2C-CN
* 2C-CP
* 2C-D
* 2C-E
* 2C-EF
* 2C-F
* 2C-G
* 2C-G-1
* 2C-G-2
* 2C-G-3
* 2C-G-4
* 2C-G-5
* 2C-G-6
* 2C-G-N
* 2C-H
* 2C-I
* 2C-iP
* 2C-N
* 2C-NH2
* 2C-O
* 2C-O-4
* 2C-P
* 2C-Ph
* 2C-SE
* 2C-T
* 2C-T-2
* 2C-T-3
* 2C-T-4
* 2C-T-5
* 2C-T-6
* 2C-T-7
* 2C-T-8
* 2C-T-9
* 2C-T-10
* 2C-T-11
* 2C-T-12
* 2C-T-13
* 2C-T-14
* 2C-T-15
* 2C-T-16
* 2C-T-17
* 2C-T-18
* 2C-T-19
* 2C-T-20
* 2C-T-21
* 2C-T-22
* 2C-T-22.5
* 2C-T-23
* 2C-T-24
* 2C-T-25
* 2C-T-27
* 2C-T-28
* 2C-T-30
* 2C-T-31
* 2C-T-32
* 2C-T-33
* 2C-TFE
* 2C-TFM
* 2C-YN
* 2C-V

| 25x-NBx|

| 25x-NB|

* 25B-NB
* 25C-NB

|

25x-NB3OMe|

* 25B-NB3OMe
* 25C-NB3OMe
* 25D-NB3OMe
* 25E-NB3OMe
* 25H-NB3OMe
* 25I-NB3OMe
* 25N-NB3OMe
* 25P-NB3OMe
* 25T2-NB3OMe
* 25T4-NB3OMe
* 25T7-NB3OMe
* 25TFM-NB3OMe

25x-NB4OMe|

* 25B-NB4OMe
* 25C-NB4OMe
* 25D-NB4OMe
* 25E-NB4OMe
* 25H-NB4OMe
* 25I-NB4OMe
* 25N-NB4OMe
* 25P-NB4OMe
* 25T2-NB4OMe
* 25T4-NB4OMe
* 25T7-NB4OMe
* 25TFM-NB4OMe

25x-NBF|

* 25B-NBF
* 25C-NBF
* 25D-NBF
* 25E-NBF
* 25H-NBF
* 25I-NBF
* 25P-NBF
* 25T2-NBF
* 25T7-NBF
* 25TFM-NBF

25x-NBMD|

* 25B-NBMD
* 25C-NBMD
* 25D-NBMD
* 25E-NBMD
* 25F-NBMD
* 25H-NBMD
* 25I-NBMD
* 25P-NBMD
* 25T2-NBMD
* 25T7-NBMD
* 25TFM-NBMD

25x-NBOH|

* 25B-NBOH
* 25C-NBOH
* 25CN-NBOH
* 25D-NBOH
* 25E-NBOH
* 25F-NBOH
* 25H-NBOH
* 25I-NBOH
* 25P-NBOH
* 25T2-NBOH
* 25T7-NBOH
* 25TFM-NBOH

25x-NBOMe|

* 25B-NBOMe
* 25C-NBOMe
* 25CN-NBOMe
* 25D-NBOMe
* 25E-NBOMe
* 25F-NBOMe
* 25G-NBOMe
* 25H-NBOMe
* 25I-NBOMe
* 25iP-NBOMe
* 25N-NBOMe
* 25P-NBOMe
* 25T-NBOMe
* 25T2-NBOMe
* 25T4-NBOMe
* 25T7-NBOMe
* 25TFM-NBOMe

Atypical structures|

* 25B-N1POMe
* 25B-NAcPip
* 25B-NB23DM
* 25B-NB25DM
* 25C-NBCl
* 25C-NBOEt
* 25C-NBOiPr
* 25I-N2Nap1OH
* 25I-N3MT2M
* 25I-N4MT3M
* 25I-NB34MD
* 25I-NBAm
* 25I-NBBr
* 25I-NBMeOH
* 25I-NBTFM
* 2CBCB-NBOMe
* 2CBFly-NBOMe
* 4-EA-NBOMe
* 5-APB-NBOMe
* 5MT-NBOMe
* C30-NBOMe
* DOB-NBOMe
* DOI-NBOMe
* FECIMBI-36
* MDPEA-NBOMe
* N-Ethyl-2C-B
* NBOMe-escaline
* NBOMe-mescaline
* ZDCM-04

25x-NMx|

* 25B-NMe7BF
* 25B-NMe7BT
* 25B-NMe7Bim
* 25B-NMe7Box
* 25B-NMe7DHBF
* 25B-NMe7Ind
* 25B-NMe7Indz
* 25B-NMePyr
* 25I-NMe7DHBF
* 25I-NMeFur
* 25I-NMeTHF
* 25I-NMeTh

N-(2C)-fentanyl|

* N-(2C-B) fentanyl
* N-(2C-C) fentanyl
* N-(2C-D) fentanyl
* N-(2C-E) fentanyl
* N-(2C-G) fentanyl
* N-(2C-H) fentanyl
* N-(2C-I) fentanyl
* N-(2C-IP) fentanyl
* N-(2C-N) fentanyl
* N-(2C-P) fentanyl
* N-(2C-T) fentanyl
* N-(2C-T-2) fentanyl
* N-(2C-T-4) fentanyl
* N-(2C-T-7) fentanyl
* N-(2C-TFM) fentanyl

3C-x|

* 3C-AL
* 3C-BZ
* 3C-DFE
* 3C-E
* 3C-MAL
* 3C-P

4C-x|

* 4C-B
* 4C-C
* 4C-D
* 4C-E
* 4C-I
* 4C-N
* 4C-P
* 4C-T-2

DOx|

* DOT
* DOB
* DOC
* DOEF
* DOET
* DOF
* DOI
* DOiPR
* DOM
* DON
* DOPR
* DOTFM
* MEM

HOT-x|

* HOT-2
* HOT-7
* HOT-17

MDxx|

* DMMDA
* DMMDA-2
* Lophophine
* MDA
* MDAI
* MDBZ
* MDMA
* MMDA
* MMDA-2
* MMDA-3a
* MMDMA

Mescaline (subst.)|

* 2-Bromomescaline
* 3-TE
* 4-TE
* 3-TM
* 4-TM
* Allylescaline
* Asymbescaline
* Buscaline
* Cyclopropylmescaline
* Difluoromescaline
* Difluoroescaline
* Escaline
* Fluoroproscaline
* Isobuscaline
* Isoproscaline
* Jimscaline
* Mescaline
* Metaescaline
* Methallylescaline
* Proscaline
* Thioproscaline
* Trifluoroescaline
* Trifluoromescaline

TMAs|

* TMA
* TMA-2
* TMA-3
* TMA-4
* TMA-5
* TMA-6

Others|

* 2C-B-BUTTERFLY
* 2C-B-DragonFLY
* 2C-B-DragonFLY-NBOH
* 2C-B-FLY-NB2EtO5Cl
* 2CB-5-hemifly
* 2CB-Ind
* 2CD-5EtO
* 2-TOET
* 5-TOET
* 2-TOM
* 5-TOM
* BOB
* BOD
* βk-2C-B
* βk-2C-I
* DESOXY
* DMCPA
* DMBMPP
* DOB-FLY
* Fenfluramine
* Ganesha
* Macromerine
* MMA
* TCB-2
* TOMSO

Piperazines|

* 2C-B-PP
* BZP
* pFPP

Tryptamines|

| alpha-alkyltryptamines|

* 4,5-DHP-α-MT
* 5-MeO-α-ET
* 5-MeO-α-MT
* α-ET
* α-MT

|

x-DALT|

* (Daltocin) 4-HO-DALT
* (Daltacetin) 4-AcO-DALT
* 5-MeO-DALT
* DALT

x-DET|

* (Ethacetin) 4-AcO-DET
* (Ethocin) 4-HO-DET
* 5-MeO-DET
* (T-9) DET
* (Ethocybin) 4-PO-DET

x-DiPT|

* (Ipracetin) 4-AcO-DiPT
* (Iprocin) 4-HO-DiPT
* 5-MeO-DiPT
* DiPT

x-DMT|

* 4,5-DHP-DMT
* 2,N,N-TMT
* 4-AcO-DMT
* 4-HO-5-MeO-DMT
* 4,N,N-TMT
* 4-Propionyloxy-DMT
* 5,6-diBr-DMT
* 5-AcO-DMT
* 5-Bromo-DMT
* 5-MeO-2,N,N-TMT
* 5-MeO-4,N,N-TMT
* 5-MeO-α,N,N-TMT
* 5-MeO-DMT
* 5-N,N-TMT
* 7,N,N-TMT
* α,N,N-TMT
* (Bufotenin) 5-HO-DMT
* DMT
* Norbaeocystin
* (Psilocin) 4-HO-DMT
* (Psilocybin) 4-PO-DMT

x-DPT|

* (Depracetin) 4-AcO-DPT
* (Deprocin) 4-HO-DPT
* 5-MeO-DPT
* (The Light) DPT

Ibogaine-related|

* 18-MAC
* 18-MC
* Coronaridine
* Ibogaine
* Ibogamine
* ME-18-MC
* Noribogaine
* Tabernanthine
* Voacangine

x-MET|

* (Metocin) 4-HO-MET
* (Metocetin) 4-AcO-MET
* 5-MeO-MET
* MET

x-MiPT|

* (Mipracetin) 4-AcO-MiPT
* (Miprocin) 4-HO-MiPT
* 5-Me-MiPT
* (Moxy) 5-MeO-MiPT
* MiPT

Others|

* 4-HO-DBT
* 4-HO-EPT
* 4-HO-McPT
* (Lucigenol) 4-HO-MPMI
* (Meprocin) 4-HO-MPT
* 5-MeO-EiPT
* 5-MeO-MALT
* 5-MeO-MPMI
* Aeruginascin
* Baeocystin
* DBT
* DCPT
* EiPT
* EPT
* MPT
* PiPT

Others|

* AL-38022A
* ALPHA
* Dimemebfe
* Efavirenz
* Glaucine
* Lorcaserin
* M-ALPHA
* RH-34
Also empathogens in general (e. g.: 5-APB, 5-MAPB, 6-APB and other substituted benzofurans).

Dissociatives
(NMDAR
antagonists)|

| Arylcyclo‐
hexylamines|

| Ketamine-related|

* 2-Fluorodeschloroketamine
* Arketamine ((R)-ketamine)
* Deschloroketamine
* Ethketamine (N-Ethylnorketamine)
* Esketamine ((S)-ketamine)
* Ketamine
* Methoxetamine
* Methoxmetamine
* Methoxyketamine
* MXiPr
* Norketamine
* Tiletamine

|

PCP-related|

* 2'-Oxo-PCE
* 3-HO-PCP
* 3-MeO-PCE
* 3-MeO-PCMo
* 3-MeO-PCP
* 4-MeO-PCP
* BDPC
* Dieticyclidine (PCDE)
* Eticyclidine (PCE)
* PCPr
* Phencyclidine (PCP)
* Rolicyclidine (PCPy)
* Tenocyclidine (TCP)

Others|

* BTCP
* Gacyclidine
* PRE-084

Diarylethylamines|

* Diphenidine
* Ephenidine
* Fluorolintane
* Methoxphenidine

Morphinans|

* Dextrallorphan
* Dextromethorphan
* Dextrorphan
* Racemethorphan
* Racemorphan

Others|

* 2-EMSB
* 2-MDP
* 8A-PDHQ
* Aptiganel
* Budipine
* Delucemine
* Dexoxadrol
* Dizocilpine
* Etoxadrol
* Herkinorin
* Ibogaine
* Midafotel
* NEFA
* Neramexane
* Nitrous oxide
* Noribogaine
* Perzinfotel
* RB-64
* Remacemide
* Selfotel
* Xenon

Deliriants
(mAChR
antagonists)|

* Atropine
* Benactyzine
* Benzatropine
* Benzydamine
* Biperiden
* BRN-1484501
* Brompheniramine
* BZ
* CAR-226,086
* CAR-301,060
* CAR-302,196
* CAR-302,282
* CAR-302,368
* CAR-302,537
* CAR-302,668
* Chloropyramine
* Chlorphenamine
* Clemastine
* CS-27349
* Cyclizine
* Cyproheptadine
* Dicycloverine
* Dimenhydrinate
* Diphenhydramine
* Ditran
* Doxylamine
* EA-3167
* EA-3443
* EA-3580
* EA-3834
* Elemicin
* Flavoxate
* Hyoscyamine
* JB-318
* JB-336
* Meclozine
* Mepyramine
* Myristicin
* Orphenadrine
* Oxybutynin
* Pheniramine
* Phenyltoloxamine
* Procyclidine
* Promethazine
* Scopolamine
* Tolterodine
* Trihexyphenidyl
* Tripelennamine
* Triprolidine
* WIN-2299

Others|

| Cannabinoids
(CB1 agonists)|

| Natural|

* Salvinorin A
* THC (Dronabinol)
* THCV

|

Synthetic|

| AM-x|

* AM-087
* AM-251
* AM-279
* AM-281
* AM-356
* AM-374
* AM-381
* AM-404
* AM-411
* AM-630
* AM-661
* AM-678
* AM-679
* AM-694
* AM-735
* AM-855
* AM-881
* AM-883
* AM-905
* AM-906
* AM-919
* AM-926
* AM-938
* AM-1116
* AM-1172
* AM-1220
* AM-1221
* AM-1235
* AM-1241
* AM-1248
* AM-1710
* AM-1714
* AM-1902
* AM-2201
* AM-2212
* AM-2213
* AM-2232
* AM-2233
* AM-2389
* AM-3102
* AM-4030
* AM-4054
* AM-4056
* AM-4113
* AM-6545

|

CP x|

* CP 47,497
* CP 55,244
* CP 55,940
* (±)-CP 55,940
* (+)-CP 55,940
* (-)-CP 55,940

HU-x|

* HU-210
* HU-211
* HU-239
* HU-243
* HU-308
* HU-320
* HU-331
* HU-336
* HU-345

JWH-x|

* JWH-007
* JWH-015
* JWH-018
* JWH-019
* JWH-030
* JWH-047
* JWH-048
* JWH-051
* JWH-057
* JWH-073
* JWH-081
* JWH-098
* JWH-116
* JWH-120
* JWH-122
* JWH-133
* JWH-139
* JWH-147
* JWH-148
* JWH-149
* JWH-149
* JWH-161
* JWH-164
* JWH-166
* JWH-167
* JWH-171
* JWH-175
* JWH-176
* JWH-181
* JWH-182
* JWH-184
* JWH-185
* JWH-192
* JWH-193
* JWH-194
* JWH-195
* JWH-196
* JWH-197
* JWH-198
* JWH-199
* JWH-200
* JWH-203
* JWH-205
* JWH-210
* JWH-210
* JWH-213
* JWH-220
* JWH-229
* JWH-234
* JWH-249
* JWH-250
* JWH-251
* JWH-253
* JWH-258
* JWH-300
* JWH-302
* JWH-307
* JWH-336
* JWH-350
* JWH-359
* JWH-387
* JWH-398
* JWH-424

Misc. designer cannabinoids|

* 4-HTMPIPO
* 5F-AB-FUPPYCA
* 5F-AB-PINACA
* 5F-ADB
* 5F-ADB-PINACA
* 5F-ADBICA
* 5F-AMB
* 5F-APINACA
* 5F-CUMYL-PINACA
* 5F-NNE1
* 5F-PB-22
* 5F-SDB-006
* A-796,260
* A-836,339
* AB-001
* AB-005
* AB-CHFUPYCA
* AB-CHMINACA
* AB-FUBINACA
* AB-PINACA
* ADAMANTYL-THPINACA
* ADB-CHMINACA
* ADB-FUBINACA
* ADB-PINACA
* ADBICA
* ADSB-FUB-187
* AMB-FUBINACA
* APICA
* APINACA
* APP-FUBINACA
* CB-13
* CUMYL-PICA
* CUMYL-PINACA
* CUMYL-THPINACA
* DMHP
* EAM-2201
* FAB-144
* FDU-PB-22
* FUB-144
* FUB-APINACA
* FUB-JWH-018
* FUB-PB-22
* FUBIMINA
* JTE 7-31
* JTE-907
* Levonantradol
* MDMB-CHMICA
* MDMB-CHMINACA
* MDMB-FUBINACA
* MEPIRAPIM
* MAM-2201
* MDA-19
* MN-18
* MN-25
* NESS-0327
* NESS-040C5
* Nabilone
* Nabitan
* NM-2201
* NNE1
* Org 28611
* Parahexyl
* PTI-1
* PTI-2
* PX-1
* PX-2
* PX-3
* QUCHIC
* QUPIC
* RCS-4
* RCS-8
* SDB-005
* SDB-006
* STS-135
* THC-O-acetate
* THC-O-phosphate
* THJ-018
* THJ-2201
* UR-144
* WIN 55,212-2
* XLR-11

D2 agonists|

* Apomorphine
* Aporphine
* Bromocriptine
* Cabergoline
* Lisuride
* LSD
* Memantine
* Nuciferine
* Pergolide
* Phenethylamine
* Piribedil
* Pramipexole
* Ropinirole
* Rotigotine
* Salvinorin A
Also indirect D2 agonists, such as dopamine reuptake inhibitors (cocaine, methylphenidate), releasing agents (amphetamine, methamphetamine), and precursors (levodopa).

GABAA
enhancers|

* CI-966
* Eszopiclone
* Ibotenic acid
* Muscimol (Amanita muscaria)
* Zaleplon
* Zolpidem
* Zopiclone

Inhalants
(Mixed MOA)|

* Aliphatic hydrocarbons
* Butane
* Gasoline
* Kerosene
* Propane
* Aromatic hydrocarbons
* Toluene
* Ethers
* Diethyl ether
* Enflurane
* Haloalkanes
* Chlorofluorocarbons
* Chloroform

κOR agonists|

* 2-EMSB
* Alazocine
* Bremazocine
* Butorphan
* Butorphanol
* Cyclazocine
* Cyclorphan
* Cyprenorphine
* Diprenorphine
* Enadoline
* Herkinorin
* Heroin
* HZ-2
* Ibogaine
* Ketazocine
* Levallorphan
* Levomethorphan
* Levorphanol
* LPK-26
* Metazocine
* Morphine
* Nalbuphine
* Nalmefene
* Nalorphine
* Noribogaine
* Oxilorphan
* Pentazocine
* Phenazocine
* Proxorphan
* Racemethorphan
* Racemorphan
* Salvinorin A
* Spiradoline
* Tifluadom
* U-50488
* U-69,593
* Xorphanol

Oneirogens|

* Calea zacatechichi
* Silene capensis
* Galantamine

Others|

* Glaucine
* Isoaminile
* Noscapine
* Pukateine

* v
* t
* e

Cannabinoid receptor modulators

Receptor
(ligands)|

| CB1Tooltip Cannabinoid receptor type 1|

* Agonists (abridged; see here for more): 2-AG
* 2-AGE (noladin ether)
* 11-Hydroxy-THC
* α-Amyrin · β-Amyrin
* AB-CHMINACA
* AM-1172
* AM-1220
* AM-1221
* AM-1235
* AM-2201
* AM-2232
* Anandamide
* Arvanil
* AZ-11713908
* Cannabinol
* CB-13
* CP 47,497
* CP 55,940
* Dimethylheptylpyran
* DEA
* ECG
* EGCG
* Epicatechin
* Gallocatechol (gallocatechin)
* Honokiol
* HU-210
* JWH-007
* JWH-015
* JWH-018
* JWH-073
* Kavain
* L-759,633
* Levonantradol
* Menabitan
* Nabilone
* Nabitan
* NADA
* O-1812
* Oleamide
* Pravadoline
* Serinolamide A
* THC (dronabinol)
* UR-144
* WIN 55,212-2
* Yangonin

* Antagonists: AM-251
* AM-6545
* Cannabidiol
* Cannabigerol
* Drinabant
* Falcarinol (carotatoxin)
* Hemopressin
* Ibipinabant
* LY-320,135
* MK-9470
* NESS-0327
* O-2050
* Otenabant
* PF-514273
* PipISB
* Rimonabant
* Rosonabant
* Surinabant
* Taranabant
* THCV
* TM-38837
* VCHSR
* Virodhamine

* Unknown/unsorted: MAFP

|

CB2Tooltip Cannabinoid receptor type 2|

* Agonists: 2-AG
* 2-AGE (noladin ether)
* 3,3'-Diindolylmethane
* 4-O-Methylhonokiol
* α-Amyrin · β-Amyrin
* A-796,260
* A-834,735
* A-836,339
* AM-1172
* AM-1221
* AM-1235
* AM-1241
* AM-2232
* Anandamide
* AZ-11713908
* Cannabinol
* Caryophyllene
* CB-13
* CBS-0550
* CP 55,940
* GW-405,833 (L-768,242)
* GW-842,166X
* HU-308
* JTE 7-31
* JWH-007
* JWH-015
* JWH-018
* JWH-73
* JWH-133
* L-759,633
* L-759,656
* Lenabasum (anabasum)
* Magnolol
* MDA-19
* Nabitan
* NADA
* Olorinab (APD-371)
* PF-03550096
* S-444,823
* SER-601
* Serinolamide A
* UR-144
* Tedalinab
* THC (dronabinol)
* THCV
* Tetrahydromagnolol
* Virodhamine

* Antagonists: 4-O-Methylhonokiol
* AM-630
* BML-190
* Cannabidiol
* Honokiol
* JTE-907
* SR-144,528
* WIN 54,461
* WIN 56,098

NAGly
(GPR18)|

* Agonists: Abnormal cannabidiol
* ACPA
* AM251
* Anandamide
* Cannabidiol
* NADGly
* THC (dronabinol)
* O-1602

* Antagonists: PSB-CB5
* O-1918

GPR55|

* Agonists: 2-AGE (noladin ether)
* 2-ALPI
* Abnormal cannabidiol
* AM-251
* CID1011163
* CID1252842
* CID1792579
* CP 55,940
* GSK-494581A
* Lysophosphatidylinositol
* ML-184
* ML-185
* ML-186
* O-1602
* Oleoylethanolamide
* Palmitoylethanolamide
* THC (dronabinol)

* Antagonists: Cannabidiol
* CID-16020046
* ML-191
* ML-192
* ML-193
* O-1918
* PSB-SB-487
* PSB-SB-1202
* PSB-SB-1203
* Tetrahydromagnolol

GPR119|

* Agonists: 2-Oleoylglycerol
* Anandamide
* APD668
* AR-231,453
* AS-1269574
* MBX-2982
* N-Oleoyldopamine
* Oleoylethanolamide
* Olvanil
* PSN-375,963
* PSN-632,408

Unsorted|

* Agonists: Revosimeline

Transporter
(modulators)|

| eCBTsTooltip Endocannabinoid transporter|

* Inhibitors: 5'-DMH-CBD
* AM-404
* AM-1172
* Arachidonoyl serotonin
* Arvanil
* Cannabidiol
* Guineensine
* LY-2183240
* O-2093
* OMDM-2
* Paracetamol (acetaminophen)
* SB-FI-26
* UCM-707
* URB-597
* VDM-11
* WOBE490
* WOBE491
* WOBE492

|

Enzyme
(modulators)|

| FAAHTooltip Fatty acid amide hydrolase|

* Inhibitors: 4-Nonylphenylboronic acid
* AACOCF3
* AM-404
* Arachidonoyl serotonin
* BIA 10-2474
* Biochanin A
* Genistein
* IDFP
* JNJ-1661010
* JNJ-42165279
* JZL-195
* Kaempferol
* LY-2183240
* MAFP
* Palmitoylisopropylamide
* Paracetamol (acetaminophen)
* PF-3845
* PF-04457845
* PF-750
* SA-47
* SA-57
* TAK 21d
* TC-F 2
* UCM710
* URB-597

* Activators: PDP-EA

|

MAGL|

* Inhibitors: ABX-1431
* IDFP
* JJKK 048
* JW 642
* JZL-184
* JZL-195
* JZP-361
* KML 29
* MAFP
* MJN110
* NAM
* Pristimerin
* URB-602

ABHD6|

* Inhibitors: JZP-169
* JZP-430
* KT182
* KT185
* KT195
* KT203
* LEI-106
* ML294
* ML295
* ML296
* UCM710
* WWL-70

ABHD12|

* Inhibitors: Betulinic acid
* Maslinic acid
* MAFP
* Oleanolic acid
* Orlistat (tetrahydrolipstatin)
* Ursolic acid

Others|

* Precursors: Phosphatidylethanolamine
* NAPE
* Diacylglycerol

* Others: 2-PG (directly potentiates activity of 2-AG at CB1 receptor)
* ARN-272 (FAAH-like anandamide transporter inhibitor)

See also
Receptor/signaling modulators
Cannabinoids (cannabinoids by structure)
*[BR]: Brazil
*[CA]: Canada
*[DE]: Germany
*[UK]: United Kingdom
*[US]: United States
*[CID]: Compound ID
*[EPA]: U.S. Environmental Protection Agency
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template
*[CBR]: Cannabinoid receptor
*[NB]: NB: N-benzyl
*[NB3OMe]: NB: N-benzyl; 3OMe: 3-methoxy
*[NB4OMe]: NB: N-benzyl; 4OMe: 4-methoxy
*[NBF]: NB: N-benzyl; F: fluoro
*[NBMD]: NB: N-benzyl; MD: methylenedioxy
*[NBOH]: NB: N-benzyl; OH: hydroxy
*[NBOMe]: NB: N-benzyl; OMe: methoxy
*[DALT]: N,N-Diallyltryptamine
*[DET]: N,N-Diethyltryptamine
*[DiPT]: N,N-Diisopropyltryptamine
*[DMT]: N,N-Dimethyltryptamine
*[DPT]: N,N-Dipropyltryptamine
*[MET]: N-Methyl-N-ethyltryptamine
*[MiPT]: N-Methyl-N-isopropyltryptamine
*[CB1]: Cannabinoid receptor type 1
*[CB2]: Cannabinoid receptor type 2
*[NAGly]: N-Arachidonyl glycine receptor
*[GPR18]: G protein-coupled receptor 18
*[GPR55]: G protein-coupled receptor 55
*[GPR119]: G protein-coupled receptor 119
*[eCBTs]: Endocannabinoid transporter
*[FAAH]: Fatty acid amide hydrolase
*[ABHD6]: alpha/beta-Hydrolase domain containing 6
*[ABHD12]: alpha/beta-Hydrolase domain containing 12